Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B

Journal of Interferon and Cytokine Research

Volumn 32, Issue 6, 2012, Pages 248-253

  Wang, Juan ^a   Cai, Yanjun ^a   Ji, Huifan ^a   Feng, Junyan ^a   Ayana, Desalegn Admassu ^b   Niu, Junqi ^a   Jiang, Yanfang ^a  

^a JILIN UNIVERSITY   (China)

^b SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; ST2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOMETRY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; LIVER INJURY; MALE; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TREATMENT DURATION;

EID: 84862176650     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0109     Document Type: Article

References (33)

1. Arshad MI, Rauch M, L'helgoualc'h A, Julia V, Leite-de-Moraes MC, Lucas-Clerc C, Samson M. 2011. NKT cells are required to induce high IL-33 expression in hepatocytes during ConAinduced acute hepatitis. Eur J Immunol 41:2341-2348.
2. Barksby HE, Lea SR, Preshaw PM, Taylor JJ. 2007. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149:17-25.
3. Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I. 2008. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 41:114-120.
4. Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S, Gombert JM, Schneider E, Dy M, Gourdy P, Girard JP, Herbelin A. 2009. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39:1046-1055.
5. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-Associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282-287. (Pubitemid 46068023)
6. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. 2007. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179:2551-2555.
7. Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM, Kim SH, Park HS, Suh CH. 2007. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27:461-466.
8. Crockett SD, Keefe EB. 2005. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 13; 4:13.
9. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, Conti P, Vecchiet J. 2006. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 36:144-150.
10. Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O, Bartenschlager R. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694-703. (Pubitemid 34183976)
11. Ghoneum M, Matsuura M. Augmentation of macrophage phagocytosis by modified arabinoxylan rice brain.2004. Int J Immunopathol Pharmacol 17:283-392.
12. Gonzalez MI, Rubinstein N, Ilarregui JM, Toscano MA, Sanjuan NA, Rabinovich GA. 2005. Regulated expression of Galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis. Int J Immunopathol Pharmacol 18:615-623.
13. Grzegorzewska AE, Wobszal P, Jagodziń ski PP. 2011. Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients. Kidney Blood Press Res 35:1-8.
14. Jiang Y, Ma Z, Xin G, Yan H, Li W, Xu H, Hao C, Niu J, Zhao P. 2010. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm 2010:143026.
15. Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR. 2003. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunol Genetics 55:362-369. (Pubitemid 37255487)
16. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures. J Viral Hepatitis 11:97-107. (Pubitemid 38365759)
17. Li A, Yuan Q, Huang Z, Fan J, Guo R, Lou B, Zheng Q, Ge S, Chen Y, Su Z, Yeo AE, Chen Y, Zhang J, Xia N. 2010. Novel double-Antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol 17(3):464-469.
18. Li DH, Kumanogoh A, Cao TM, Parnes JR, Cullen JM. 2004. Woodchuck interleukin-6 gene: structure, characterization and biologic activity. Gene 342:157-164. (Pubitemid 39457188)
19. Liew FY, Pitman NI, McInnes IB. 2010. Disease-Associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103-110, Review.
20. Louten J, Rankin AL, Li Y, Murphy EE, Beaumont M, Moon C, Bourne P, McClanahan TK, Pflanz S. 2011. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses duringallergic airway inflammation. Int Immunol 23:307-315.
21. Martini F, Agrati C, D'Offizi G, Poccia F. 2005. HLA-E upregulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int J Immunopathol Pharmacol 18:269-276. (Pubitemid 40825889)
22. Marvie P, Lisbonne M, L'helgoualc'h A, Rauch M, Turlin B, Preisser L, Bourd-Boittin K, Theret N, Gascan H, Piquet-Pellorce C, Samson M. 2010. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 14:1726-1739.
23. Miyagaki T, Sugaya M, Yokobayashi H, Kato T, Ohmatsu H, Fujita H, Saeki H, Kikuchi Y,Tamaki T, Sato S. 2011. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection. J Invest Dermatol 131(3):794-796.
24. Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, Lam KF, Xu D. 2010. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 49:520-527.
25. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Campos R, Ernst D, Gaur A. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110:252-266. (Pubitemid 38402005)
26. Rehermann B. 2000. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20:127-141. (Pubitemid 30618712)
27. Rehermann B, Nascimbeni M. 2005. Immunology of hepatitis b virus and hepatitis c virus infection. Nat Rev 5(3):215-229. (Pubitemid 40364823)
28. Roth GA, Zimmermann M, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG, Ankersmit HJ. 2010. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J Surg Res 163:e79-e83.
29. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23:479-484.
30. Tárnok A, Hambsch J, Chen R, Varro R. 2003. Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin Chem 49:1000-1002. (Pubitemid 36623495)
31. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N, Lukic ML. 2012. Protective role of IL-33/ST2 axis in con A-Induced Hepatitis. J Hepatol 56:26-33.
32. Yang Z, Liang Y, Xi W, Li C, Zhong R. 2011. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med 11:75-80.
33. Yim HJ, Lok AS. 2006. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43:S173-S181.